Author

Juliane C. Wilcke

Institut für Medizinische Informationsverarbeitung, Biometrie und EpidemiologieORCID 0009-0005-7675-6669Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Scientific Communication & Education· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Anne‐Laure BoulesteixiD· 2 shared Sebastian KoboldiD· 2 shared Ana BanitoiD· 1 shared Anca Kliesow RemesiD· 1 shared Andrea Matzen· 1 shared Arunabh SharmaiD· 1 shared Astrid DempfleiD· 1 shared Bernhard HalleriD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersScientific Communication & Education

Anne‐Laure BoulesteixORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-Lab Testing of Early Preclinical Discoveries Identifies Promising Treatments

Pasquale Pellegrini, Sophia C. Rotter, María Arroyo-Araujo, Clarissa F. D. Carneiro, Natascha Drude, Lorena Martinez‐Gamboa, Ana Banito, Nadine Rabe Bernhardt, Anne‐Laure Boulesteix, Frank Buttgereit, Astrid Dempfle, Nayar Durán-Hernández, Timo Gaber, Marcus Groettrup, Bettina Habelt, , Ulf Toelch

The paper evaluates multi-laboratory studies to identify promising treatments by assessing effect sizes and experimental rigor across different medical fields.

bioRxiv · Oct 30, 2026 · PreprintScientific Communication & Education

Multicenter preclinical validation of next-generation CAR T cells: a strategy for harmonization, reproducibility, and its feasibility in clinical translation

Iman Dalloul, Markus Barden, Juliane C. Wilcke, Sophie Bernhard, Nicole Ellenbach, Anne‐Laure Boulesteix, Hinrich Abken, Sebastian Kobold

This paper validates a multicenter preclinical strategy for CAR T cells, demonstrating its feasibility in confirming CCR8 overexpression benefits across multiple centers.

bioRxiv · Apr 10, 2026 · PreprintSynthetic Biology